Drug firm Alembic Pharmaceuticals Ltd on Friday (February 14) said it has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for its solid oral ...

Alembic Ltd. key Products/Revenue Segments include Income From Real Estate Development, Rent, Job Work, API, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2024.For the ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Following an inspection carried out from Nov 14-22 2024, the facility was cited as being ‘VAI’ (Voluntary Action Indicated).